Coronary Artery Disease in Patients Undergoing Transvalvular Aortic Valve Implantation.

ABSTRACT: Coronary artery disease (CAD) is common in patients with severe aortic stenosis. With the advent of transcatheter aortic valve implantation (TAVI) as a therapeutic option, management of CAD in such patients has undergone a revolution. Younger patients are now candidates for treatment, and have a greater life-time probability of requiring post-TAVI coronary access. Considerations include pre-procedural assessment and revascularisation, procedural planning to avoid coronary obstruction as well as optimisation of post-procedural coronary access. The authors review the challenges of managing CAD in TAVI patients, shed light on the evidence base, and provide guidance on how to optimise management.

SUBMITTER: Lim Y 

PROVIDER: S-EPMC9585643 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature